Director, Precision Medicine Clinical Biomarker Scientist
$136K-$208K (Glassdoor est.)
ROLE SUMMARY

The Precision Medicine Clinical Biomarker Scientist works collaboratively across research, technical, and clinical teams to define and operationalize early clinical biomarker strategies. A successful candidate can communicate and lead within a matrix organization, multitask/prioritize multiple projects, and leverage information from a variety of sources in order to deliver effective, fit for purpose biomarker strategies, quality data, and interpretation of biomarker results to drive program decisions.

ROLE RESPONSIBILITIES
Collaborates with research and clinical colleagues to develop and defend scientifically rigorous translational and exploratory biomarker strategies that assess proof of mechanism, establish early signs of efficacy, enable proof of concept studies, and generate an understanding of the variability in patient response
Assembles and leads collaborative biomarker sub-teams, made up of colleagues with relevant technical, research, or clinical expertise, to operationalize biomarker strategy
Ensures timely biomarker assay development, fit for purpose validation and resourcing
Contributes clinical protocol, lab manual, and informed consent language specific to biomarkers
Leverages external contract research organizations and vendors along with appropriate internal laboratories to execute biomarker analyses
Serves on clinical operations teams to endure compliance around clinical biospecimen management and vendor oversight
Ensures timely delivery of internally or externally generated biomarker data for analysis
Works with biomarker and clinical teams to interpret biomarker results in the context of the clinical study
Shares learnings with key stakeholders and the scientific community through presentations and peer-reviewed publications.
QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
PhD with minimum of 7-10 years of experience. Industry experience strongly preferred
Background in metabolic, cardiovascular, inflammatory, or rare genetic diseases preferred
Candidate should have advanced knowledge of the application of various biomarker technologies (eg. flow cytometry, ligand binding assays, mass spectrometry) as well as various high dimensional exploratory platforms (eg. transcriptomic, proteomic, metabolomics)
Experience in clinical drug development, clinical protocol design, clinical trial operations, clinical trial biospecimen logistics, analytical and clinical validation of biomarker assays, and/or vendor interactions preferred
Able to effectively lead matrix teams made up of research, technical, and clinical colleagues
Builds connections by developing positive, collaborative partnerships
Demonstrated ability to manage and contribute effectively to multiple projects at once
Highly effective verbal and written communication skills
#LI-PFE
Reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider’s name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.
Medical
Pfizer
4.0
Pfizer
